RZLT
Rezolute, Inc.
Latest Form 4:Purchase$29KbyEvans Daron (CFO) · filed Mar 31, 2026
Rezolute, Inc. (RZLT) has 12 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 7, 2026.
- Industry:Biotechnology
- CEO:Nevan Charles Elam
- Employees:74
- HQ:Redwood City, CA, US
- IPO:2013-01-14
Insider Buying
$236K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$442.9M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Evans DaronFirst in 4 months | CFO | Purchase | 10,000 | $29K | Mar 31 | SEC ↗ |
Hogenhuis WladimirFirst filing | Director | Purchase | 5,650 | $10K | Dec 17 | SEC ↗ |
ROBERTS BRIAN KENNETHFirst filing | Chief Medical Officer | Purchase | 28,000 | $48K | Dec 17 | SEC ↗ |
Evans DaronFirst filing | CFO | Purchase | 45,000 | $80K | Dec 15 | SEC ↗ |
Karnawat Sunil RatilalFirst filing | Chief Commercial Officer | Purchase | 12,100 | $20K | Dec 15 | SEC ↗ |
Elam Nevan CFirst filing | CEO | Purchase | 32,000 | $51K | Dec 15 | SEC ↗ |
Related companies
Rezolute, Inc. is in the Healthcare sector.